Cannonau Corp 最大收入來源為 Therapeutic Products for Oncology,在最近的收益報告中收入為 76,994,000。就地區而言,United States 是 Cannonau Corp 的主要市場,收入為 76,994,000。
Cannonau Corp 是否盈利?
無,根據最新的財務報表,Cannonau Corp 的淨損失為 $0
Cannonau Corp 有負債嗎?
無,Cannonau Corp 的負債為 0
Cannonau Corp 的流通股有多少?
Cannonau Corp 的總流通股為 241.81
關鍵數據
前收市價
$0.0003
開盤價
$0.0002
當日範圍
$0.0002 - $0.0002
52週區間
$0.0001 - $0.0401
交易量
1.5K
平均成交量
431
股息收益率
--
每股盈餘 (TTM)
0.00
市值
$48.2K
什麼是 CNNC?
Cannonau Corp. engages in the development of cannabidiol-based products. The company is headquartered in Skaneateles, New York and currently employs 0 full-time employees. The company went IPO on 2008-02-11. The firm uses nanotechnology plans to offer the advanced CBD for improved bioavailability and benefit.